asa glp 1 agonist guidelines Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: a restrictive fasting regimen is not necessary. Comment on Br J Anaesth 2025; 135: 48–78 Perioperative management of patients taking
Description
Summary GLP-1 RAs offer a multifaceted therapeutic strategy in PD, targeting both central neurodegenerative processes and peripheral metabolic dysfunction
However, the coexistence of micro and macrovascular disease is associated with the highest cardiovascular risks which highlights the importance that pharmacological treatment of type 2 diabetes mellitus provides not only glycemic control, but also cardiovascular safety
Learn why experts say it's a "real-time experiment" you shouldn't risk.
The key takeaway
Here is what the evidence says about protecting your bones and muscle on GLP-1 therapy.
